Quantum BioPharma shares are trading lower after the company announced a non-brokered private placement offering and plans to settle outstanding debts with shares. These financial maneuvers suggest potential dilution concerns among investors.

60 Degrees Pharmaceuticals shares are trading higher after the company announced all patients in their expanded use clinical trial were cured of babesiosis using tafenoquine treatment, highlighting a potential breakthrough in vector-borne disease treatment.

Broadwind shares are trading lower after reporting a net loss for Q4 2025 due to raw material supply disruptions impacting manufacturing throughput, and a decline in the Gearing segment revenue despite overall revenue growth.

BODi shares are trading higher after the company reported a significant improvement in operating income and positive net earnings for the second consecutive quarter, signaling a successful financial turnaround.

Actelis Networks shares are trading higher after securing a significant order from the Japanese government for its cyber-hardened networking solutions aimed at modernizing critical infrastructure.

NextPlat shares are trading higher after its subsidiary, Global Telesat Communications, was awarded an $820,000 satellite-enabled connectivity hardware and services contract from a UK government prime supplier.

Target Hospitality shares are trading higher after the company announced securing over $740 million in multi-year contracts and significant advancements in strategic growth initiatives.

Serve Robotics shares are trading higher after the company announced a partnership with White Castle to provide autonomous delivery via Uber Eats.

Cyngn shares are trading higher after the company announced they are on track to surpass total sales of 2025 in just Q1 of 2026 due to increased customer demand and expanded deployments.

Kala Bio shares are trading higher after the company announced it is ready to ship its first commercial AI product within approximately 14 days, potentially transforming the biotech landscape.

Skye Bioscience shares are trading lower after the company reported a significant increase in net losses for the fourth quarter and full year 2025, primarily due to increased research and development expenses and contract manufacturing costs.

Ballard Power Systems shares are trading higher after announcing a commercial agreement with New Flyer for 50 MW of fuel cell bus engines.

AeroVironment shares are trading lower after the company reported a significant goodwill impairment charge of $151.3 million in its Space unit, negatively affecting third quarter financial results.

Motorsport Games Inc. shares are trading higher after the company reported a strong fourth quarter and full-year 2025 financial results, showcasing significant revenue growth and a turnaround to profitability.

Citius Pharmaceuticals shares are trading higher after the company announced positive topline results from a Phase 1 study of LYMPHIR™ in combination with pembrolizumab for relapsed or refractory gynecologic cancers.

Co-Diagnostics shares are trading higher after the company announced it regained compliance with Nasdaq listing requirements.

NIO shares are trading lower after the company reported financial results that, despite showing significant growth in vehicle deliveries and revenues for 2025, revealed a continued net loss for the year. The contrast between revenue growth and persisting losses appears to have unsettled investors.

Kosmos Energy shares are trading lower after the company announced a registered underwritten public offering of 97,500,000 shares at $1.90 each, aimed at repaying outstanding debt.

Oracle shares are trading higher after the company reported better-than-expected Q3 financial results, with cloud revenue up 44% year-over-year, GAAP earnings per share rising to $1.27, and a significant 325% increase in Remaining Performance Obligations.

CVG shares are trading higher after the company reported a significant improvement in its fourth-quarter 2025 financial performance, driven by a 155.6% increase in adjusted EBITDA and a notable enhancement in gross margin.